Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2000
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012064A1 Omeprazole formulation
03/09/2000WO2000011952A1 Compositions and methods for treatment of mitochondrial diseases
03/09/2000WO1999058123A3 Novel fatty acid analogues for the treatment of primary and secondary restenosis
03/09/2000WO1998052600A9 Methods of enhancing functioning of the upper gastrointestinal tract
03/09/2000DE19838809A1 Trockenextrakt aus der Hennapflanze, Verfahren zu dessen Herstellung und dessen Verwendung Dry extract of the henna plant, process for its preparation and its use
03/09/2000CA2696878A1 Compositions and methods for treatment of mitochondrial diseases
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342209A1 Omeprazole formulation
03/09/2000CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341612A1 Indazole derivatives with 5-ht2 receptor activity
03/09/2000CA2341543A1 Pyrazine compounds
03/09/2000CA2341525A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984013A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane
03/08/2000EP0984004A2 Trisubstituted-piperidinyl-N-alkylcarboxylates as opioid antagonists
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983263A1 Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
03/08/2000EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
03/08/2000EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983251A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
03/08/2000EP0983228A1 Protease inhibitors
03/08/2000EP0983079A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
03/08/2000CN1246866A Monocyclic compounds with four bifunctional residues having NK-2 antagonist action
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246850A 1,5-benzodiazepine derivatives
03/08/2000CN1246848A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1246341A Health-care medicinal powder
03/08/2000CN1050132C Ginkgotide derivatives
03/08/2000CN1050128C 5-acrylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/08/2000CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034134 1-Amino-alkylcyclohexane NMDA receptor antagonists
03/07/2000US6034127 Amidino protease inhibitors
03/07/2000US6034113 Derivatives of 1,3,4-oxadiazolone
03/07/2000US6034087 Nucleoside derivatives and process for preparing thereof
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein
03/07/2000US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation.
03/07/2000US6033864 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011029A2 Novel anti-diabetic peptides
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011010A1 Phosphoglycolipid and methods for its use
03/02/2000WO2000011000A2 New compounds
03/02/2000WO2000010999A2 New compounds
03/02/2000WO2000010995A1 Novel salt form of pantoprazole
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010572A1 Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010529A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010528A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010527A1 Oral mucoadhesive compositions containing gastrointestinal actives
03/02/2000WO2000010526A2 New oral formulation for 5-ht4 agonists or antagonists
03/02/2000WO2000010520A1 Toothpaste comprising fine and coarse calcium carbonate
03/02/2000WO1999065513A3 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
03/02/2000WO1999064409A3 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
03/02/2000WO1999064043A9 Muscarinic receptor antagonists
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058555A3 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
03/02/2000WO1999056767A3 Method for treating cytokine mediated hepatic injury
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2340649A1 Phosphoglycolipid and methods for its use
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
1 ... 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 ... 1258